For example, bamlanivimab (LY-CoV555), a human IgG1 targeting the RBD of S protein, was discovered by Eli-Lilly and AbCellera from single antigen-specific B cells of a COVID-19 convalescent patient [43]. Here, PROS1 is linked to COVID-19.